PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.77%
Revenue growth above 1.5x UPM.HE's 2.19%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
7.65%
Gross profit growth under 50% of UPM.HE's 37.07%. Michael Burry would be concerned about a severe competitive disadvantage.
-0.91%
Negative EBIT growth while UPM.HE is at 83.06%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-0.91%
Negative operating income growth while UPM.HE is at 83.06%. Joel Greenblatt would press for urgent turnaround measures.
-3.88%
Negative net income growth while UPM.HE stands at 112.78%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.23%
Negative EPS growth while UPM.HE is at 112.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-3.23%
Negative diluted EPS growth while UPM.HE is at 112.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.24%
Share reduction while UPM.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.68%
Reduced diluted shares while UPM.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-97.08%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-429.73%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
14.89%
Positive 10Y revenue/share CAGR while UPM.HE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
50.41%
5Y revenue/share CAGR above 1.5x UPM.HE's 4.01%. David Dodd would look for consistent product or market expansions fueling outperformance.
39.55%
Positive 3Y CAGR while UPM.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
107.78%
Positive long-term OCF/share growth while UPM.HE is negative. John Neff would see a structural advantage in sustained cash generation.
-92.02%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-91.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-29.93%
Negative 10Y net income/share CAGR while UPM.HE is at 220.57%. Joel Greenblatt sees a major red flag in long-term profit erosion.
233.33%
5Y net income/share CAGR above 1.5x UPM.HE's 38.10%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
200.00%
3Y net income/share CAGR above 1.5x UPM.HE's 15.51%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
99.92%
10Y equity/share CAGR above 1.5x UPM.HE's 45.80%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
75.89%
5Y equity/share CAGR above 1.5x UPM.HE's 35.93%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
39.83%
3Y equity/share CAGR above 1.5x UPM.HE's 14.88%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
155.52%
5Y dividend/share CAGR above 1.5x UPM.HE's 36.73%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
56.16%
3Y dividend/share CAGR above 1.5x UPM.HE's 0.00%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-100.00%
Firm’s AR is declining while UPM.HE shows 22.26%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
8.25%
Inventory shrinking or stable vs. UPM.HE's 26.65%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-3.18%
Negative asset growth while UPM.HE invests at 7.63%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.95%
1.25-1.5x UPM.HE's 2.36%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-1.37%
We’re deleveraging while UPM.HE stands at 54.80%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
10.20%
SG&A growth of 10.20% while UPM.HE is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.